Creating a system to track and improve HIV prevention efforts using PrEP data
Establishing PREMISE: A PrEP Epidemiology, Modeling, and Surveillance System
This study is looking at how well people are using a medication called PrEP to prevent HIV, especially in communities that might not have easy access to it, so we can find better ways to help everyone stay healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11009421 on NIH RePORTER |
What this research studies
This research aims to establish a comprehensive system called PREMISE that will collect and analyze national data on the use of pre-exposure prophylaxis (PrEP) for HIV prevention. By examining patterns of PrEP uptake and the effectiveness of various programs and policies, the research seeks to identify strategies that enhance access to and use of PrEP, particularly among underserved populations. The team will utilize diverse datasets and legal coding to understand the impact of different local policies on PrEP utilization. This approach will help inform public health responses to the HIV epidemic and improve prevention efforts across the United States.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for HIV who may benefit from PrEP, particularly within Black communities.
Not a fit: Patients who are not at risk for HIV or those who are already receiving effective HIV prevention measures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to HIV prevention methods for at-risk populations, ultimately reducing the incidence of HIV.
How similar studies have performed: Previous research has shown that targeted programs and policies can significantly increase PrEP uptake, indicating that this approach has potential for success.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Siegler, Aaron Julius — Emory University
- Study coordinator: Siegler, Aaron Julius
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.